BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

785 related articles for article (PubMed ID: 17601630)

  • 1. Cyclodextrins as pharmaceutical solubilizers.
    Brewster ME; Loftsson T
    Adv Drug Deliv Rev; 2007 Jul; 59(7):645-66. PubMed ID: 17601630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cyclodextrin solubilization of drugs.
    Loftsson T; Hreinsdóttir D; Másson M
    Int J Pharm; 2005 Sep; 302(1-2):18-28. PubMed ID: 16099118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclodextrins in drug delivery.
    Loftsson T; Jarho P; Másson M; Järvinen T
    Expert Opin Drug Deliv; 2005 Mar; 2(2):335-51. PubMed ID: 16296758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-assembled cyclodextrin aggregates and nanoparticles.
    Messner M; Kurkov SV; Jansook P; Loftsson T
    Int J Pharm; 2010 Mar; 387(1-2):199-208. PubMed ID: 19963052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of cyclodextrins for enhancing oral bioavailability.
    Carrier RL; Miller LA; Ahmed I
    J Control Release; 2007 Nov; 123(2):78-99. PubMed ID: 17888540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical applications of cyclodextrins: basic science and product development.
    Loftsson T; Brewster ME
    J Pharm Pharmacol; 2010 Nov; 62(11):1607-21. PubMed ID: 21039545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-assembly of cyclodextrin complexes: aggregation of hydrocortisone/cyclodextrin complexes.
    Messner M; Kurkov SV; Brewster ME; Jansook P; Loftsson T
    Int J Pharm; 2011 Apr; 407(1-2):174-83. PubMed ID: 21237259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclodextrins as functional excipients: methods to enhance complexation efficiency.
    Loftsson T; Brewster ME
    J Pharm Sci; 2012 Sep; 101(9):3019-32. PubMed ID: 22334484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclodextrin solubilization of the antibacterial agents triclosan and triclocarban: formation of aggregates and higher-order complexes.
    Duan MS; Zhao N; Ossurardóttir IB; Thorsteinsson T; Loftsson T
    Int J Pharm; 2005 Jun; 297(1-2):213-22. PubMed ID: 15885935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclodextrins.
    Kurkov SV; Loftsson T
    Int J Pharm; 2013 Aug; 453(1):167-80. PubMed ID: 22771733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative interaction of 2-hydroxypropyl-beta-cyclodextrin and sulfobutylether-beta-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions.
    Brewster ME; Vandecruys R; Peeters J; Neeskens P; Verreck G; Loftsson T
    Eur J Pharm Sci; 2008 Jul; 34(2-3):94-103. PubMed ID: 18420390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes.
    Loftsson T; Brewster ME
    J Pharm Pharmacol; 2011 Sep; 63(9):1119-35. PubMed ID: 21827484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical properties of water and its effect on drug delivery. A commentary.
    Loftsson T; Brewster ME
    Int J Pharm; 2008 Apr; 354(1-2):248-54. PubMed ID: 17920796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of chemically modified cyclodextrins in the development of formulations for chemical delivery systems.
    Brewster ME; Loftsson T
    Pharmazie; 2002 Feb; 57(2):94-101. PubMed ID: 11878196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization.
    Loftsson T; Brewster ME
    J Pharm Sci; 1996 Oct; 85(10):1017-25. PubMed ID: 8897265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing the cyclodextrin complexation of drugs and drug biovailability through addition of water-soluble polymers.
    Loftsson T
    Pharmazie; 1998 Nov; 53(11):733-40. PubMed ID: 9853355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inclusion complexes of azadirachtin with native and methylated cyclodextrins: solubilization and binding ability.
    Liu Y; Chen GS; Chen Y; Lin J
    Bioorg Med Chem; 2005 Jun; 13(12):4037-42. PubMed ID: 15911316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aqueous solubility and true solutions.
    Loftsson T
    Pharmazie; 2010 Jun; 65(6):404-7. PubMed ID: 20614686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDs as solubilizers: effects of excipients and competing drugs.
    Jansook P; Loftsson T
    Int J Pharm; 2009 Sep; 379(1):32-40. PubMed ID: 19524652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.